Wildwood, MO, United States of America

Lijuan Jane Wang

This inventor holds 44 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent, primarily in Cholesterol Inhibition. Top assignees: Pharmacia Corporation, G.d. Searle & Company, Pfizer Corporation. Active years: 2002-2016.

USPTO Granted Patents = 44 

% Patents Active = 9.1

 

 

Average Co-Inventor Count = 14.1

ph-index = 8

Forward Citations = 264(Granted Patents)


Location History:

  • Wildwood, MI (US) (2004)
  • Wildwood, MO (US) (2002 - 2016)

Company Filing History:


Years Active: 2002-2016

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Cholesterol Ester Transfer Protein
Protease Inhibitors
Nitric Oxide Synthase
Amino Compounds
Hydroxamic Acids
Chiral Halogenated Compounds
Biaryl Ether Urea
Heterocyclic Amino Compounds
Sulfonylmethyl Hydroxamic Acids
Aromatic Sulfone
Reverse Aminoalcohol
Fused Heterocyclic Compounds
44 patents (USPTO):Explore Patents

Title: Inventor Lijuan Jane Wang - Pioneering Innovations in Wildwood

Introduction: Lijuan Jane Wang is a visionary inventor based in Wildwood, Missouri, known for her groundbreaking contributions to the field of technology and beyond.

Latest Patents: Wang holds several patents in various industries, including cutting-edge advancements in renewable energy, healthcare technology, and sustainable materials.

Career Highlights: With a career spanning over two decades, Wang has established herself as a leading figure in the innovation landscape, consistently pushing the boundaries of what is possible.

Collaborations: Throughout her career, Wang has collaborated with top research institutions, universities, and forward-thinking companies to bring her ideas to life and make a lasting impact on society.

Conclusion: Lijuan Jane Wang's dedication to innovation and her relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…